Routine insider filing for a new CMO. No trading signal. Monitor for any subsequent Form 4 filings that would indicate actual share purchases or sales by the officer.
Price Chart
Executive Summary
Form 3 initial beneficial ownership filing for Dr. Dimitris Voliotis, newly appointed Chief Medical Officer of Radiopharm Theranostics Ltd. The filing discloses only option grants with no direct share ownership, indicating a standard equity incentive package for an incoming executive officer.
Key Facts
- Dimitris Voliotis appointed Chief Medical Officer of Radiopharm Theranostics Ltd
- Voliotis reports zero non-derivative securities (no direct share ownership)
- Three tranches of stock options granted: 7,657,333 options each at A$0.025 exercise price, expiring 2030-07-01
- Option vesting dates: 2026-07-01, 2027-07-01, and 2028-07-01
- Total potential option holdings: 22,972,000 ordinary shares (if all options exercised)
- Filing date: 2026-05-06, period of report: 2026-03-18
Financial Impact
No financial impact. Options are at nominal exercise price (A$0.025) and represent standard executive compensation.
Risk Factors
- Potential future dilution from option exercises (22.97M shares) if all options vest and are exercised
- No insider buying signal — zero direct share ownership suggests limited alignment with shareholders at this point
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-052990 |
| Document: 0001213900-26-052990-index.html | 0001213900-26-052990 |
| Document: 0001213900-26-052990.txt | 0001213900-26-052990 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 3, 2026 20w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −52.50% | $0.006660 (−66.70%) |
May 6, 2026 24w ago | 3 | $0.0200 $0.0100 | ▼ −50.00% | ▼ −53.83% | $0.006660 (−66.70%) |
Apr 23, 2026 26w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −55.02% | $0.006660 (−66.70%) |
Apr 16, 2026 27w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −57.05% | $0.006660 (−66.70%) |
Apr 8, 2026 28w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −60.46% | $0.006660 (−66.70%) |
Apr 7, 2026 28w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −63.27% | $0.006660 (−66.70%) |
Apr 1, 2026 29w ago | 3 | $0.0200 $0.0100 | ▼ −50.00% | ▼ −64.16% | $0.006660 (−66.70%) |
Mar 27, 2026 30w ago | 6-K | $0.0200 $0.0200 | · 0.00% | ▼ −16.07% | $0.006660 (−66.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers